company

Biomedisyn Corporation

as of 2026-07-01
Monitor thisAsk about this
at a glance
1 trials sponsored · 3 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

3 assets
huperzine 0.2 mg BIDhuperzine 0.4 mg BIDhuperzine 0.8 mg BID

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
huperzine 0.2 mg BID
small molecule
drug
huperzine 0.4 mg BID
small molecule
drug
huperzine 0.8 mg BID
small molecule
drug